Not Yet RecruitingNot Applicable

The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders

China158 participantsStarted 2026-04-25

Plain-language summary

The trail aimed to test the efficacy of AI-based rehabilitation treatment in patients with anxiety disorders. Specifically, the objective of this trial is to determine whether the AI-based rehabilitation combined with treatment as usual is more effective than treatment as usual alone in improving outcomes in patients with anxiety disorders.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

1\. Subjects with anxiety disorders * Inclusion Criteria: * In accordance with ICD-11 for Anxiety Disorders; * Between the ages of 18-60; * Completed at least 9 years of education; * Ability to use computers or smartphone; * Native Chinese speaker; * Signing informed consent. * Exclusion Criteria: * With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment; * Use of cognitive-enhancing medications within the past 6 months; * With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.

What they're measuring

Change from baseline in anxiety symptoms, as measured by the Generalized Anxiety Disorder 7-item Scale (GAD-7)

Timeframe: Assessed at baseline (T0), immediately post-intervention at week 3 (T1), and follow-up at week 7 (T2).

Trial details

NCT IDNCT07545070

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-25

View on ClinicalTrials.gov More Anxiety Disorders trials